Audit 8469

FY End
2022-06-30
Total Expended
$1.10M
Findings
12
Programs
6
Organization: Palo Alto County Hospital (IA)
Year: 2022 Accepted: 2023-12-26

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
6497 2022-003 Material Weakness Yes ABCIL
6498 2022-004 Significant Deficiency - I
6499 2022-005 Significant Deficiency - L
6500 2022-003 Material Weakness Yes ABCIL
6501 2022-004 Significant Deficiency - I
6502 2022-005 Significant Deficiency - L
582939 2022-003 Material Weakness Yes ABCIL
582940 2022-004 Significant Deficiency - I
582941 2022-005 Significant Deficiency - L
582942 2022-003 Material Weakness Yes ABCIL
582943 2022-004 Significant Deficiency - I
582944 2022-005 Significant Deficiency - L

Contacts

Name Title Type
UQMLYV8W4JT1 Collette Johnson Auditee
7128525500 Ryan Engebretson Auditor
No contacts on file

Notes to SEFA

Title: BASIS OF PRESENTATION Accounting Policies: No funds were identified as having been provided to subrecipients by the Health System and accordingly, no funds identified in the Schedule of Expenditures of Federal Awards are attributable to subrecipient entities. There were no federal awards expended for noncash assistance or insurance. De Minimis Rate Used: Y Rate Explanation: The Health System has elected to use the 10% de minimis indirect cost rate allowable under the Uniform Guidance. The accompanying schedule of expenditures of federal awards includes the federal grant activity of Palo Alto County Hospital dba: Palo Alto County Health System (the Health System) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the applicable requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule of expenditures of federal awards presents only a selected portion of the operations of the Health System, it is not intended to and does not present the financial position, changes in net position, or cash flows of the Health System.
Title: RECONCILATION OF SEFA AND FINANCIAL STATEMENTS Accounting Policies: No funds were identified as having been provided to subrecipients by the Health System and accordingly, no funds identified in the Schedule of Expenditures of Federal Awards are attributable to subrecipient entities. There were no federal awards expended for noncash assistance or insurance. De Minimis Rate Used: Y Rate Explanation: The Health System has elected to use the 10% de minimis indirect cost rate allowable under the Uniform Guidance. The financial statements reflect revenue recognized from the Provider Relief Fund of approximately $174,350 for the year ended June 30, 2022. The SEFA includes Provider Relief Funds of $175,333 that were received in Periods 2 and 3 in accordance with the requirements of the compliance supplement for assistance listing number 93.498. The difference is due to the Health System recognizing $983 of revenue related to the Provider Relief Funds in the year ended June 30, 2021, when the funds were utilized.

Finding Details

Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Material Weakness in Internal Control over Compliance Criteria or specific requirement: 2 CFR 200.303(a) states that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Health System did not have documented formal controls and procedures over compliance with federal awards. Condition: The Health System did not have documented formal review processes over the use of the federal awards or required reporting for the federal awards. Eligible uses of federal awards were tracked in detail, and required reporting under the federal award was completed, but there was not a formal review or approval process in place. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. The Health System's CFO maintained this schedule as eligible uses of funds were identified throughout the organization, reviewed activity, and reconciled the schedule to the general ledger. There was not, however, documentation of a formal review or approval, outside of the schedule being maintained and reconciled. Similarly, the Health System CFO completed the required reporting under the federal award based on the schedule discussed above and other supporting documentation, but there was no formal review or approval process for that report. The Health System does have in place review processes and controls over all expenditures (AP, Payroll), they are just not designed specifically to consider compliance with federal programs. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore more formal controls and procedures around the use of federal awards had not been in place. Effect: Without formal control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: Yes – 2021-003 Recommendation: We recommend that management implement more formal control process surrounding the use of federal awards where there is segregation between individuals identifying or proposing expenditures/uses of funds and an individual reviewing and approving that expenditure/use. We also recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained in both cases. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: The Code of Federal Regulations section 200.320 states the non-Federal entity must have and use documented procurement procedures following specific requirements for different methods of procurement depending on size and type of purchase. Thresholds for these categories (micro-purchase, simplified acquisition threshold) refer to using the Federal Acquisition Regulations (FAR), unless a different threshold has been specifically approved. Specifically, under FAR multiple quotes are generally required for purchases over the micro-purchase threshold, or documentation should be maintained explaining why multiple quotes were not obtained. Condition: During our testing, we noted the Health System did not have a properly documented procurement policy that met the federal requirements. As a result there were vendors over the micro purchase threshold that were tested where retained documentation was not sufficient to support procurement method or noncompetitive procurement in line with federal requirements. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. Eligible expenditures were reviewed by the CFO and followed standard organizational internal control processes (i.e., AP), but ultimately did not follow a procurement policy in line with Uniform Guidance requirements. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and policies around the use of federal awards had not been in place. Effect: The lack of documented procurement policies over these compliance requirements provides an opportunity for noncompliance. Repeat finding: No Recommendation: We recommend the Health System create and implement a procurement policy that meets the requirements of federal regulations. The Health System should also maintain documentation to support procurement method used and compliance with policy when procuring vendors for federal grant funded projects. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: Per the notice of award, the annual FFR for the MAT grant is due January 30 for budget periods ending in August through October. The Health System's budget period ended on 8/31/21 for the report in question. Condition: The Health System did not have a process in place to ensure timely filing of required reports and report was filed one day late. Questioned costs: None Context: The Health System maintained detailed accounting records to accurately report on annual grant expenditures but did not have a process in place to ensure timely filing of required reports. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and procedures around the use of federal awards had not been in place. Effect: Without proper control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: No Recommendation: We recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained. We also recommend implementing procedures or a schedule to ensure required reporting is filed timely. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Material Weakness in Internal Control over Compliance Criteria or specific requirement: 2 CFR 200.303(a) states that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Health System did not have documented formal controls and procedures over compliance with federal awards. Condition: The Health System did not have documented formal review processes over the use of the federal awards or required reporting for the federal awards. Eligible uses of federal awards were tracked in detail, and required reporting under the federal award was completed, but there was not a formal review or approval process in place. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. The Health System's CFO maintained this schedule as eligible uses of funds were identified throughout the organization, reviewed activity, and reconciled the schedule to the general ledger. There was not, however, documentation of a formal review or approval, outside of the schedule being maintained and reconciled. Similarly, the Health System CFO completed the required reporting under the federal award based on the schedule discussed above and other supporting documentation, but there was no formal review or approval process for that report. The Health System does have in place review processes and controls over all expenditures (AP, Payroll), they are just not designed specifically to consider compliance with federal programs. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore more formal controls and procedures around the use of federal awards had not been in place. Effect: Without formal control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: Yes – 2021-003 Recommendation: We recommend that management implement more formal control process surrounding the use of federal awards where there is segregation between individuals identifying or proposing expenditures/uses of funds and an individual reviewing and approving that expenditure/use. We also recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained in both cases. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: The Code of Federal Regulations section 200.320 states the non-Federal entity must have and use documented procurement procedures following specific requirements for different methods of procurement depending on size and type of purchase. Thresholds for these categories (micro-purchase, simplified acquisition threshold) refer to using the Federal Acquisition Regulations (FAR), unless a different threshold has been specifically approved. Specifically, under FAR multiple quotes are generally required for purchases over the micro-purchase threshold, or documentation should be maintained explaining why multiple quotes were not obtained. Condition: During our testing, we noted the Health System did not have a properly documented procurement policy that met the federal requirements. As a result there were vendors over the micro purchase threshold that were tested where retained documentation was not sufficient to support procurement method or noncompetitive procurement in line with federal requirements. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. Eligible expenditures were reviewed by the CFO and followed standard organizational internal control processes (i.e., AP), but ultimately did not follow a procurement policy in line with Uniform Guidance requirements. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and policies around the use of federal awards had not been in place. Effect: The lack of documented procurement policies over these compliance requirements provides an opportunity for noncompliance. Repeat finding: No Recommendation: We recommend the Health System create and implement a procurement policy that meets the requirements of federal regulations. The Health System should also maintain documentation to support procurement method used and compliance with policy when procuring vendors for federal grant funded projects. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: Per the notice of award, the annual FFR for the MAT grant is due January 30 for budget periods ending in August through October. The Health System's budget period ended on 8/31/21 for the report in question. Condition: The Health System did not have a process in place to ensure timely filing of required reports and report was filed one day late. Questioned costs: None Context: The Health System maintained detailed accounting records to accurately report on annual grant expenditures but did not have a process in place to ensure timely filing of required reports. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and procedures around the use of federal awards had not been in place. Effect: Without proper control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: No Recommendation: We recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained. We also recommend implementing procedures or a schedule to ensure required reporting is filed timely. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Material Weakness in Internal Control over Compliance Criteria or specific requirement: 2 CFR 200.303(a) states that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Health System did not have documented formal controls and procedures over compliance with federal awards. Condition: The Health System did not have documented formal review processes over the use of the federal awards or required reporting for the federal awards. Eligible uses of federal awards were tracked in detail, and required reporting under the federal award was completed, but there was not a formal review or approval process in place. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. The Health System's CFO maintained this schedule as eligible uses of funds were identified throughout the organization, reviewed activity, and reconciled the schedule to the general ledger. There was not, however, documentation of a formal review or approval, outside of the schedule being maintained and reconciled. Similarly, the Health System CFO completed the required reporting under the federal award based on the schedule discussed above and other supporting documentation, but there was no formal review or approval process for that report. The Health System does have in place review processes and controls over all expenditures (AP, Payroll), they are just not designed specifically to consider compliance with federal programs. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore more formal controls and procedures around the use of federal awards had not been in place. Effect: Without formal control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: Yes – 2021-003 Recommendation: We recommend that management implement more formal control process surrounding the use of federal awards where there is segregation between individuals identifying or proposing expenditures/uses of funds and an individual reviewing and approving that expenditure/use. We also recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained in both cases. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: The Code of Federal Regulations section 200.320 states the non-Federal entity must have and use documented procurement procedures following specific requirements for different methods of procurement depending on size and type of purchase. Thresholds for these categories (micro-purchase, simplified acquisition threshold) refer to using the Federal Acquisition Regulations (FAR), unless a different threshold has been specifically approved. Specifically, under FAR multiple quotes are generally required for purchases over the micro-purchase threshold, or documentation should be maintained explaining why multiple quotes were not obtained. Condition: During our testing, we noted the Health System did not have a properly documented procurement policy that met the federal requirements. As a result there were vendors over the micro purchase threshold that were tested where retained documentation was not sufficient to support procurement method or noncompetitive procurement in line with federal requirements. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. Eligible expenditures were reviewed by the CFO and followed standard organizational internal control processes (i.e., AP), but ultimately did not follow a procurement policy in line with Uniform Guidance requirements. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and policies around the use of federal awards had not been in place. Effect: The lack of documented procurement policies over these compliance requirements provides an opportunity for noncompliance. Repeat finding: No Recommendation: We recommend the Health System create and implement a procurement policy that meets the requirements of federal regulations. The Health System should also maintain documentation to support procurement method used and compliance with policy when procuring vendors for federal grant funded projects. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: Per the notice of award, the annual FFR for the MAT grant is due January 30 for budget periods ending in August through October. The Health System's budget period ended on 8/31/21 for the report in question. Condition: The Health System did not have a process in place to ensure timely filing of required reports and report was filed one day late. Questioned costs: None Context: The Health System maintained detailed accounting records to accurately report on annual grant expenditures but did not have a process in place to ensure timely filing of required reports. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and procedures around the use of federal awards had not been in place. Effect: Without proper control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: No Recommendation: We recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained. We also recommend implementing procedures or a schedule to ensure required reporting is filed timely. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Material Weakness in Internal Control over Compliance Criteria or specific requirement: 2 CFR 200.303(a) states that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Health System did not have documented formal controls and procedures over compliance with federal awards. Condition: The Health System did not have documented formal review processes over the use of the federal awards or required reporting for the federal awards. Eligible uses of federal awards were tracked in detail, and required reporting under the federal award was completed, but there was not a formal review or approval process in place. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. The Health System's CFO maintained this schedule as eligible uses of funds were identified throughout the organization, reviewed activity, and reconciled the schedule to the general ledger. There was not, however, documentation of a formal review or approval, outside of the schedule being maintained and reconciled. Similarly, the Health System CFO completed the required reporting under the federal award based on the schedule discussed above and other supporting documentation, but there was no formal review or approval process for that report. The Health System does have in place review processes and controls over all expenditures (AP, Payroll), they are just not designed specifically to consider compliance with federal programs. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore more formal controls and procedures around the use of federal awards had not been in place. Effect: Without formal control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: Yes – 2021-003 Recommendation: We recommend that management implement more formal control process surrounding the use of federal awards where there is segregation between individuals identifying or proposing expenditures/uses of funds and an individual reviewing and approving that expenditure/use. We also recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained in both cases. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: The Code of Federal Regulations section 200.320 states the non-Federal entity must have and use documented procurement procedures following specific requirements for different methods of procurement depending on size and type of purchase. Thresholds for these categories (micro-purchase, simplified acquisition threshold) refer to using the Federal Acquisition Regulations (FAR), unless a different threshold has been specifically approved. Specifically, under FAR multiple quotes are generally required for purchases over the micro-purchase threshold, or documentation should be maintained explaining why multiple quotes were not obtained. Condition: During our testing, we noted the Health System did not have a properly documented procurement policy that met the federal requirements. As a result there were vendors over the micro purchase threshold that were tested where retained documentation was not sufficient to support procurement method or noncompetitive procurement in line with federal requirements. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. Eligible expenditures were reviewed by the CFO and followed standard organizational internal control processes (i.e., AP), but ultimately did not follow a procurement policy in line with Uniform Guidance requirements. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and policies around the use of federal awards had not been in place. Effect: The lack of documented procurement policies over these compliance requirements provides an opportunity for noncompliance. Repeat finding: No Recommendation: We recommend the Health System create and implement a procurement policy that meets the requirements of federal regulations. The Health System should also maintain documentation to support procurement method used and compliance with policy when procuring vendors for federal grant funded projects. Views of responsible officials: There is no disagreement with the audit finding.
Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Significant Deficiency in Internal Control over Compliance and Other Matters Criteria or specific requirement: Per the notice of award, the annual FFR for the MAT grant is due January 30 for budget periods ending in August through October. The Health System's budget period ended on 8/31/21 for the report in question. Condition: The Health System did not have a process in place to ensure timely filing of required reports and report was filed one day late. Questioned costs: None Context: The Health System maintained detailed accounting records to accurately report on annual grant expenditures but did not have a process in place to ensure timely filing of required reports. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore, more formal controls and procedures around the use of federal awards had not been in place. Effect: Without proper control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: No Recommendation: We recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained. We also recommend implementing procedures or a schedule to ensure required reporting is filed timely. Views of responsible officials: There is no disagreement with the audit finding.